19 results on '"Misurski, D."'
Search Results
2. PCN27 - Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib
3. PCN14 - Network Meta-Analysis of Treatments For Unresectable Hepatocellular Carcinoma
4. PCN2 - Detrimental Impact of Toxicity on Quality of Life In Hepatocellular Carcinoma Patients Treated with Lenvatinibor Sorafenib
5. PHS134 - The market for Hepatitis C services in Alberta
6. PHS68 - Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis C
7. PGI21 - Cost-effectiveness of treating Hepatitis C Virus (HCV) Genotype 1 (GT1) patients with abbvie 3D (Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir) +/- ribavirin compared to harvoni (Sofosbuvir/Ledipasvir) in the United States
8. PIN16 HEALTH CARE UTILIZATION AND COSTS ASSOCIATED WITH HEPATITIS A IN A US COMMERCIALLY INSURED POPULATION
9. PIN13 LONG-TERM ECONOMIC AND CLINICAL BURDEN OF COMPLICATED INVASIVE MENINGOCOCCAL DISEASE: EVIDENCE FROM A UNITED STATES MANAGED CARE POPULATION
10. PDB60 ASSESSMENT OF THE INTERVAL BETWEEN FIRST EXENATIDE CLAIM AND LAST PRIOR ORAL ANTIDIABETIC CLAIM
11. PDB15 UTILIZATION PATTERNS AND HYPOGLYCEMIA IN PATIENTS WITH TYPE-2 DIABETES ON CONCOMITANT EXENATIDE AND LONG-ACTING INSULIN THERAPY
12. PDB7 ADMINISTRATIVE CLAIMS ANALYSIS OF PATIENTS WITH TYPE-2 DIABETES INITIATING SITAGLIPTIN THERAPY
13. PDB6 18 MONTH A1C AND WEIGHT OUTCOMES OF EXENATIDE THERAPY IN PATIENTS WITH TYPE-2 DIABETES IN A REAL-WORLD STUDY
14. PDB2 A1C AND WEIGHT OUTCOMES FOLLOWING 6 MONTHS OF ANALOG BASAL INSULIN IN INSULIN NAÏVE PATIENTS WITH TYPE-2 DIABETES IN AN AMBULATORY CARE SETTING
15. DB3 REAL-WORLD ANALYSIS OF PERCENT OF PATIENTS WITH TYPE 2 DIABETES ACHIEVING GLYCEMIC GOAL WITH INSULIN GLARGINE
16. PDB67 DESCRIPTIVE ANALYSIS OF BODY WEIGHT AND CLINICAL EFFECTIVENESS MEASURES ASSOCIATED WITH TYPE 2 DIABETES THERAPIES IN A PRIMARY CARE ELECTRONIC MEDICAL RECORD DATABASE
17. PDB1 EXENATIDE UTILIZATION AND EFFECTIVENESS IN A HEALTH PLAN POPULATION
18. PDB57 ADMINISTRATIVE CLAIMS ANALYSIS OF NEW EXENATIDE PATIENTS WITH TYPE 2 DIABETES
19. PDB58 CHANGES IN CONCOMITANT DIABETES THERAPIES ASSOCIATED WITH THE INITIATION OF EXENATIDE IN PATIENTS WITH TYPE 2 DIABETES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.